Aspire biopharma holdings inc ASBP.US Value Analysis
US StockHealth Care
(No presentation for ASBP)
ASBP Value Score
3
24
15
Poor Growth
- AI analysis rates ASBP with the lowest value score of 1.
- It is mainly due to unstable operating cash flow, along with potential higher debt.
- Over the past 3 months, ASBP has maintained an average value rating of 0.3, close to the rating of 0.3 over the past 3 years, indicating low growth opportunities for enterprise value.
- Compared to all stocks in the Health Care sector, ASBP has a lower value rating.
ASBP Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
No related data records
ASBP Financial Forecast
Unit : USD
Update to 2025/5/23 (Quarterly Update)
ASBP Earnings Table
No related data records
ASBP Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
ASBP Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of ASBP from 2022/04 till Now
- -
- Cumulative Return
- -
- Annual Return
- -
- Volatility
- -
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from April, 2022 to May, 2025. (Total Trades: 0)
| ASBP | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | - | 44% | 54% |
| Avg Return | - | 63% | 74.4% |
| Avg Profit | - | 197.7% | 169.1% |
| Avg Loss | - | -44.8% | -34.5% |
| Avg Risk-Reward Ratio | - | 440.8% | 489.6% |
Update to 2025/5/24 (Daily Update)